APA (7th ed.) Citation

Chang, T., Yan, Y., Yu, Z., Rathore, M., Lee, N., Tseng, H., . . . Lee, S. (2024). Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models. Journal of Clinical Investigation, 134(23), 1. https://doi.org/10.1172/JCI165448

Chicago Style (17th ed.) Citation

Chang, Ting-Yu, et al. "Combined HDAC8 and Checkpoint Kinase Inhibition Induces Tumor-selective Synthetic Lethality in Preclinical Models." Journal of Clinical Investigation 134, no. 23 (2024): 1. https://doi.org/10.1172/JCI165448.

MLA (9th ed.) Citation

Chang, Ting-Yu, et al. "Combined HDAC8 and Checkpoint Kinase Inhibition Induces Tumor-selective Synthetic Lethality in Preclinical Models." Journal of Clinical Investigation, vol. 134, no. 23, 2024, p. 1, https://doi.org/10.1172/JCI165448.